TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Tango Therapeutics Appoints Sung Lee to Board of Directors

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
Tango Therapeutics Appoints Sung Lee to Board of Directors

Tango Therapeutics announced the appointment of Sung Lee, Executive Vice President and CFO at Cytokinetics, to its Board of Directors. Lee brings over 20 years of finance leadership experience from roles at major biopharmaceutical companies including Vir Biotechnology, MorphoSys, Sangamo Therapeutics, and Gilead Sciences. His appointment is intended to support Tango's advancement of its lead program vopimetostat into registrational studies.

Insights
TEL   positive

Provides critical IoT components, benefits from 20% annual IoT market growth, positioned at the center of AI's physical infrastructure expansion


CYTK   neutral

Cytokinetics is mentioned only as Sung Lee's current employer. His departure to join Tango's board could be viewed as neutral or slightly negative for Cytokinetics, but the article provides no direct information about impact on Cytokinetics' operations or strategy.